US Patent 11033626 Progesterone formulations having a desirable pk profile
Patent 11033626 was granted and assigned to TherapeuticsMD on June, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 20, 2019
0
Date of Patent
June 15, 2021
0
Patent Applicant
Patent Application Number
16578148
0
Patent Citations Received
Patent Inventor Names
Peter H. R. Persicaner
0
Thorsteinn Thorsteinsson
0
Brian Bernick
0
Frederick Sancilio
0
Janice Cacace
0
Julia Amadio
0
Neda Irani
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11033626 Progesterone formulations having a desirable pk profile
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
